Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 97-105 , March 2008

Hypertension prevention and control in Canada

  • Norman R.C. Campbell, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Norman R. C. Campbell, MD, Libin Cardiovascular Institute of Alberta, Health Sciences Centre, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 4N1 Canada.

Received 23 July 2007 ,Accepted 4 October 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Norman Campbell acknowledges the Canadian Institutes of Health Research for their support of the Canada Chair in Hypertension Prevention and Control. Dr. Campbell has provided talks for and sits on Advisory Boards of most pharmaceutical companies that produce antihypertensive drugs in Canada.

PII: S1933-1711(07)00203-3

doi: 10.1016/j.jash.2007.10.001

Journal of the American Society of Hypertension
Volume 2, Issue 2 , Pages 97-105 , March 2008

Article Tools

* Image Usage & Resolution